Prevention and Treatment of Substance Using Populations with or at Risk for HCV (R01)

Funding Opportunity PA-14-137 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (R01) outlines priority areas for high impact clinical and basic research for at-risk substance using populations, including those infected with or at risk for HIV. In particular, this FOA encourages research focused on prevention and treatment of Hepatitis C Virus (HCV) to reduce new infections and identify and treat existing infections more effectively. This FOA is informed by priority areas in the 2011 HHS Action Plan, Combating the Silent Epidemic of Viral Hepatitis: Action Plan for the Prevention, Care and Treatment of Viral Hepatitis.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding